ascendis pharma glp-1 FDA Approves Pharma's Yuviwel for Achondroplasia | PharmaShots posted on the topic GLP1-SM - Ascend BioHealth

Learn key terms, medication types, and tips to manage your treatment with clarity and confidence.

Yesterday, the FDA published a reminder clarifying the status of compounded Tirzepatide now that the shortage for this GLP-1 product has been resolved.

Had missed this detail @Humana was selected by CMS as the central processor for the Medicare GLP-1 Bridge Makes sense given Humana already administers prescription drug access for the LI NET program

Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.

In animal studies, GLP-1 agonists triggered anxiety early in treatment which then subsided and shifted toward reduced depression-like behaviour with continued use